🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,82 USD

Máx. histórico

178,74

2145 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,03%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,42%

Cierre anterior

17,57

Rango de hoy

17,52 – 18,77

Volumen hoy

2.596.193

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 14 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
14/04/2015 13,67 13,76 13,35 13,56 -0,88% 3,00% 642.200
13/04/2015 13,81 13,94 13,55 13,68 -1,23% 2,82% 659.100
10/04/2015 14,14 14,14 13,75 13,85 -1,56% 2,76% 738.900
09/04/2015 14,22 14,43 13,70 14,07 -1,12% 5,13% 655.500
08/04/2015 14,52 14,65 14,10 14,23 -1,66% 3,79% 680.700
07/04/2015 14,79 14,99 14,25 14,47 -1,77% 5,00% 1.095.300
06/04/2015 14,24 15,12 14,07 14,73 +3,37% 7,37% 1.414.800
02/04/2015 14,30 14,35 13,77 14,25 -0,28% 4,06% 943.400
01/04/2015 14,13 14,30 13,50 14,29 +7,61% 5,66% 2.129.900
31/03/2015 13,70 13,92 13,15 13,28 -4,25% 5,62% 623.000
30/03/2015 13,66 14,09 13,54 13,87 +2,21% 4,03% 822.200
27/03/2015 13,08 13,68 13,08 13,57 +3,83% 4,59% 763.900
26/03/2015 12,80 13,20 12,66 13,07 +0,54% 4,22% 537.500
25/03/2015 13,50 13,59 12,98 13,00 -3,63% 4,52% 1.025.000
24/03/2015 13,26 13,50 13,15 13,49 +2,04% 2,64% 530.500
23/03/2015 13,19 13,35 12,75 13,22 +0,46% 4,55% 771.500
20/03/2015 13,97 14,47 13,12 13,16 -5,46% 9,66% 1.550.200
19/03/2015 13,63 13,95 13,60 13,92 +1,90% 2,57% 489.600
18/03/2015 13,54 13,80 13,35 13,66 +0,52% 3,32% 572.600
17/03/2015 13,76 13,81 13,30 13,59 -1,45% 3,71% 504.900
16/03/2015 14,12 14,12 13,68 13,79 -2,27% 3,12% 601.800
13/03/2015 14,08 14,24 13,76 14,11 +0,50% 3,41% 461.800
12/03/2015 13,93 14,08 13,71 14,04 +0,57% 2,66% 418.900
11/03/2015 13,61 14,07 13,43 13,96 +2,95% 4,70% 559.000
10/03/2015 13,31 13,71 13,22 13,56 -0,22% 3,68% 369.600
09/03/2015 13,69 13,85 13,35 13,59 -0,29% 3,65% 364.800
06/03/2015 14,00 14,09 13,51 13,63 -3,20% 4,14% 529.400
05/03/2015 14,13 14,39 13,85 14,08 +0,14% 3,82% 531.100
04/03/2015 13,36 14,07 13,15 14,06 +5,24% 6,89% 802.000
03/03/2015 13,40 13,55 13,05 13,36 -0,96% 3,73% 658.100